Alcohol
Volume 44, Issue 3 , Pages 223-228 , May 2010

Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease

  • Garth R. Swanson

      Affiliations

    • Department Digestive Diseases, Rush University Medical Center, Chicago, IL 60612-3824, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-312-563-3871; fax: +1-312-563-3945.
    • ,
  • Shahriar Sedghi

      Affiliations

    • Department of Internal Medicine, Mercer University School of Medicine, Macon, GA 31201, USA
    • ,
  • Ashkan Farhadi

      Affiliations

    • Department Digestive Diseases, Rush University Medical Center, Chicago, IL 60612-3824, USA
    • ,
  • Ali Keshavarzian

      Affiliations

    • Department Digestive Diseases, Rush University Medical Center, Chicago, IL 60612-3824, USA

Received 22 April 2009 ,Revised 10 October 2009 ,Accepted 31 October 2009.

References 

  1. Adams PF, Schoenborn CA. Health behaviors of adults: United states, 2002-04. Vital Health Stat. 2006;10(230):1–140
  2. Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R. Review article: the pathophysiology of gastro-oesophageal reflux disease—oesophageal manifestations. Aliment. Pharmacol. Ther. 2004;(20 Suppl 9):14–25
  3. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001;120(5):1093–1099
  4. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106(3):643–648
  5. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763–786
  6. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol. 2000;95(4):1008–1013
  7. Green JT, Rhodes J, Ragunath K, Thomas GA, Williams GT, Mani V, et al. Clinical status of ulcerative colitis in patients who smoke. Am. J. Gastroenterol. 1998;93(9):1463–1467
  8. Hey H, Schmedes A, Nielsen AA, Winding P, Gronbaek H. Effects of five different alcoholic drinks on patients with Crohn's disease. Scand. J. Gastroenterol. 2007;42(8):968–972
  9. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53(10):1479–1484
  10. Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J. Clin. Sleep Med. 2006;2(4):409–416
  11. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am. J. Gastroenterol. 1994;89(12):2205–2211
  12. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 1991;13(2):267–276
  13. Klatsky AL. Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacol. Res. 2007;55(3):237–247
  14. Mandrekar P, Catalano D, Dolganiuc A, Kodys K, Szabo G. Inhibition of myeloid dendritic cell accessory cell function and induction of T cell energy by alcohol correlates with decreased IL-12 production. J. Immunol. 2004;173(5):3398–3407
  15. Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006;131(2):410–419
  16. Norkina O, Dolganiuc A, Shapiro T, Kodys K, Mandrekar P, Szabo G. Acute alcohol activates STAT3, AP-1, and sp-1 transcription factors via the family of src kinases to promote IL-10 production in human monocytes. J. Leukoc. Biol. 2007;82(3):752–762
  17. Pace F, Molteni P, Bollani S, Sarzi-Puttini P, Stockbrügger R, Bianchi Porro G, et al. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand. J. Gastroenterol. 2003;38(10):1031–1038
  18. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754–760
  19. Romelsjo A, Leifman H, Nystrom S. A comparative study of two methods for the measurement of alcohol consumption in the general population. Int. J. Epidemiol. 1995;24(5):929–936
  20. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm. Bowel Dis. 2005;11(2):154–163
  21. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122(2):512–530
  22. Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig. Dis. Sci. 1988;33(2):129–134
  23. Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H. Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol. Clin. Exp. Res. 2000;24(3):390–394
  24. Wyatt J, Oberhuber G, Pongratz S, Püspök A, Moser G, Novacek G, et al. Increased gastric and intestinal permeability in patients with Crohn's disease. Am. J. Gastroenterol. 1997;92(10):1891–1896

PII: S0741-8329(10)00024-8

doi: 10.1016/j.alcohol.2009.10.019

Alcohol
Volume 44, Issue 3 , Pages 223-228 , May 2010

Article Tools

* Image Usage & Resolution